Logo

Revvity

In Brief This Week: Revvity, IntelliGenome, Angle, NowDiagnostics, Pramana

News items for the week of Jan. 20, 2025.

JP Morgan Healthcare Conference, Day 1: Exact Sciences, Revvity, Qiagen, Guardant Health, Waters

Highlights from the first day included updates from Exact Sciences about its plans for new tests slated for this year and beyond.

Revvity, Element Biosciences to Collaborate on Newborn Sequencing Workflow

Revvity separately said that it expects Q4 2024 revenue growth of 5 percent, or 6 percent organically, year over year.

FDA Clears Revvity Free Testosterone Assay

The chemiluminescence-based immunoassay is used for the direct quantitative measurement of free testosterone in serum or plasma, with results in 48 minutes.

Revvity Enters Into $1.5B Credit Facility

The firm said that the unsecured $1.5 billion revolving credit facility through 2030 replaces another $1.5 billion credit facility through 2026.

Nov 22, 2024

In Brief This Week: QuidelOrtho, Revvity, CeGaT, Mindera Health, Fluxergy, NeuroKaire, More

Nov 4, 2024

China Instrument Sales Drag on Revvity Life Science Segment as Company Q3 Revenues Rise 2 Percent
Premium

Oct 28, 2024

BARDA Awards Revvity $9.2M, Partners With Sherlock Biosciences for COVID/Flu Home Tests

Oct 25, 2024

In Brief This Week:, Hologic, Revvity, Pillar Biosciences, Mainz Biomed, More

Oct 21, 2024

Top Five Articles on 360Dx Last Week: Lab Priorities During Elections; Cepheid TB Test Pricing; More

Oct 15, 2024

Barclays Upgrades Revvity to Overweight

Oct 2, 2024

Revvity Gets CE Mark for PCR Test Used to Guide Alzheimer's Therapy

Jul 29, 2024

Revvity Q2 Revenues Drop 2 Percent on Softer Life Sciences Sales Tempered by Dx Growth

Jul 26, 2024

In Brief This Week: Agilent Technologies; Danaher; Labcorp; Hologic; Invitae; More

Apr 29, 2024

Revvity Executes Organizational Restructuring; Q1 Revenues Beat Wall Street Expectations
Premium

Apr 26, 2024

In Brief This Week: Labcorp; Revvity; BGI Genomics; Genetic Technologies; Revna Biosciences

Apr 25, 2024

Revvity to Provide Genome Sequencing for North Carolina Newborn Screening Study Under Deal With RTI

Apr 25, 2024

Revvity's Euroimmun Inks European Distribution Deal for ALPCO-GeneProof PCR Tests

Apr 2, 2024

Revvity Granted Preliminary Injunction Against Cloud Software Group in Contract Dispute

Apr 1, 2024

Revvity Launches NGS Panel, Workflow to Complement Current Newborn Screening
Premium

Mar 21, 2024

Revvity Seeks Injunction Against Cloud Software Group Over Alleged Contract Violations

Feb 23, 2024

Three-Year FNIH-Led Study Could Clear a Path for Earlier Preeclampsia Tests in the US
Premium

Feb 1, 2024

Revvity Q4 Non-COVID Revenues Decline 3 Percent

Jan 26, 2024

In Brief This Week: Becton Dickinson, Revvity, Tempus, Pacific Edge, Centogene, Amadix

Jan 10, 2024

JP Morgan Healthcare Conference, Day 2: Danaher, Abbott, Thermo Fisher Scientific, Revvity, More